Measuring influenza vaccine efficacy: what is the comparator?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Study shows different influenza vaccine effectiveness (IVE) estimates with different control groups.

Why this matters

  • Pan-negative controls may be less valid for estimating IVE because many of these patients may have noninfectious causes of influenza-like illness (ILI) or acute respiratory infection (ARI). 

Study design

  • Test-negative design, case-control study.
  • Dutch Sentinel Practices of NIVEL Primary Care Database.
  • Patients with known influenza vaccination status swabbed for ILI or ARI.
  • IVE estimated from 2003/2004 to 2013/2014.
  • Adjusted for age, diagnosis, chronic disease, and respiratory allergy.
  • 3 sets of controls: testing negative for influenza only (group 1); but positive for respiratory syncytial viruses, rhinovirus, or enterovirus (group 2); and “pan-negative’ for all viruses tested (group 3).
  • Funding: Du...